Robinson Ryan F. 4
4 · Tourmaline Bio, Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
Robinson Ryan F.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-22$13.92/sh+14,366$199,975→ 14,366 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-10-22−14,366→ 25,845 totalExercise: $13.92Exp: 2033-08-14→ Common Stock (14,366 underlying)
Footnotes (1)
- [F1]The shares subject to the option vested as to 25% of the shares on July 5, 2024 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.